Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Private Placement Warrants
Public Warrants
Common Stock
Common Stock
Private Placement Warrants
Common Stock
Public Warrants
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement Warrants
Additional Paid-In Capital
Public Warrants
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Common stock, beginning balance (in shares) at Dec. 31, 2024       784,176,364              
Beginning balance at Dec. 31, 2024 $ 912,363     $ 78     $ 2,768,605     $ (1,855,737) $ (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (82,406)                 (82,406)  
Stock-based compensation 27,019           27,019        
Issuance of common stock upon exercise of stock options (in shares)       807,475              
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options 547           547        
Issuance of common stock upon release of restricted stock units (in shares)       4,063,821              
Issuance of common stock in Offering, net of issuance cost (in shares)       246,167              
Issuance of common stock in Offering, net of issuance cost 1,994     $ 1     1,993        
Vesting of early exercised stock options 13           13        
Other comprehensive loss (89)                   (89)
Common stock, ending balance (in shares) at Mar. 31, 2025       789,293,827              
Ending balance at Mar. 31, 2025 $ 859,441     $ 79     2,798,177     (1,938,143) (672)
Common stock, beginning balance (in shares) at Dec. 31, 2025 915,076,698     915,076,698              
Beginning balance at Dec. 31, 2025 $ 1,409,713     $ 91     4,193,684     (2,785,579) 1,517
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (109,950)                 (109,950)  
Stock-based compensation 41,161           41,161        
Issuance of common stock upon exercise of stock options (in shares)       691,952              
Issuance of common stock upon exercise of stock options and vesting of early exercised stock options 512           512        
Issuance of common stock upon release of restricted stock units (in shares)       5,003,139              
Issuance of common stock in Offering, net of issuance cost (in shares)       52,863,437              
Issuance of common stock in Offering, net of issuance cost 576,336     $ 6     576,330        
Issuance of common stock upon exercise of warrants (in shares)         7,000,000 3,174          
Issuance of common stock upon exercise of warrants   $ 70,000 $ 47   $ 1     $ 69,999 $ 47    
Reclassification of Delta warrant liability upon exercise 37,870           37,870        
Payment for capped call transactions (63,273)           (63,273)        
Other comprehensive loss $ (4,705)                   (4,705)
Common stock, ending balance (in shares) at Mar. 31, 2026 980,638,400     980,638,400              
Ending balance at Mar. 31, 2026 $ 1,957,711     $ 98     $ 4,856,330     $ (2,895,529) $ (3,188)